4:52 PM
 | 
Jan 22, 2019
 |  BC Extra  |  Company News

Management tracks: GSK, A*STAR, Moderna

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Philip Hampton will step down as chairman ahead of the pharma’s planned split of its consumer healthcare and innovative R&D businesses. The pharma said it has started to search for a successor to Hampton, who has been chairman since May 2015 (see “GSK, Pfizer JV allows Both Pharmas to Focus on Innovation”).

Singapore’s Agency for Science Technology and Research...

Read the full 305 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >